Burden of eosinophilic granulomatosis with polyangiitis by disease phase and steroid-sparing effects of biologics: a real-world retrospective study in Europe
Although the vasculitic subgroup showed the greatest disease severity, all subgroups demonstrated a substantial disease burden. Results also suggest biologics provide OCS-sparing effects and improve disease control in real-world settings.
Authors
- Jeremiah Hwee (ORCID: https://orcid.org/0000-0002-2623-7706)
- Lynn Huynh (ORCID: https://orcid.org/0000-0003-3110-6775)
- Thanai Pongdee (ORCID: https://orcid.org/0000-0002-4725-242X)
- Rafael Alfonso‐Cristancho (ORCID: https://orcid.org/0000-0002-7060-5131)
- Mei Sheng Duh (ORCID: https://orcid.org/0000-0001-5035-6687)
- Wilson Luiz da Costa (ORCID: https://orcid.org/0000-0003-4460-4706)
Institutions
- Health Outcomes Solutions (United States) (US)
- GlaxoSmithKline (Canada) (CA)
- Mayo Clinic in Florida (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1183/23120541.00310-2025
- Primary Topic
- Eosinophilic Disorders and Syndromes
- Type
- article
- Field-Weighted Citation Impact
- 0.00